Intelligent Optical Systems, Inc.

Intelligent Optical Systems, Inc., a Gardena, California-based small business manufacturer, develops miniaturized optical sensing and instrumentation technologies for federal research and development programs, operating as a prime contractor on 98 percent of its federal awards and competes under Total Small Business set-asides across SBIR and STTR programs, federal grants, and research contracts.

The company's portfolio spans advanced optical sensor development, laser ultrasonic testing, point-of-care diagnostic assays, and environmental monitoring systems. Recent representative work includes a $1.3 million Defense Health Agency Sequential Phase II SBIR award (March 2024) for an enhanced rapid assay for monitoring immunosuppressant drugs in whole blood, a $2.0 million Defense Health Agency military medical research grant (September 2025) for comprehensive immune response profiling in severe polytrauma using multimodal advanced monitoring, a $382.5 thousand National Cancer Institute SBIR contract (September 2024) for a fingerstick blood test for point-of-care detection of prostate specific antigen, and a pair of $156 thousand Shared Services Center SBIR Phase I contracts (September 2025) for in-situ trace-gas detection and laser ultrasonic testing for in-space welding. The company also holds a $520 thousand Centers for Disease Control and Prevention Investigations and Technical Assistance grant (September 2026) for a low-swap phosgene clip detector and a $181.5 thousand Department of Agriculture SBIR grant (September 2025) for a compact ammonia monitoring system for enclosed livestock housing, performed in collaboration with CTB, Inc.

Customer concentration is dispersed across research agencies. NASA Shared Services Center leads by award count and potential value with 30 awards ($10.1 million combined), followed by the National Institutes of Health (19 awards) and NASA proper (16 awards, $670 thousand). Dollar concentration shows NASA Shared Services Center anchoring the portfolio at $10.1 million, with the Army Medical Command ($3.9 million across 7 awards), Army Materiel Command Research Development and Engineering Command ($3.6 million across 5 awards), Naval Air Systems Command Naval Air Warfare Center ($2.7 million across 6 awards), and the Department of Homeland Security Science and Technology Directorate ($2.4 million across 8 awards) comprising the next tier. The top five customers by potential value represent 49 percent of combined potential dollars. The company serves 62 distinct customer agencies in recent award history.

Intelligent Optical Systems sits on the Information Analysis Center Multiple-Award Contract with five task orders. The primary vehicle portfolio reflects the nature of its customer base — SBIR and STTR programs dominate (55 awards under "Research and Development in the Physical, Engineering, and Life Sciences except Biotechnology" NAICS; 33 awards under space R&D services PSC), with smaller volumes under applied research and exploratory development contracts. Nine awards carrying combined potential value of $2.4 million face ultimate completion within the next twenty-four months and therefore expose the vendor to recompete activity. Subcontract volume is minimal; the company subcontracts to MriGlobal for chemical, biological, radiological, and nuclear defense evaluation work involving colorimetric identification of blister and nerve agents on chemically-sensitive paper formats. Combined potential value across all awards stands at $46 million, though obligated dollars ($98.8 million across the full lifetime dataset) exceed potential value by 215 percent, indicating high Phase II continuation and follow-on award activity from completed SBIR Phase I work. Activity peaked in 2023 with 13 awards and has modulated to 6 in 2025 and 1 in 2026 (as of September), reflecting the cyclical nature of SBIR solicitations and the compressed timeframe of recent awards near the source data collection date.

Research and Development of technologies, including optical sensors and biosensors for environmental, medical, space, and defense applications, innovative colorimetric chemical and biological agent detection platforms, nondestructive visual and laser ultrasonic inspection systems, rapid assay biomarker detection methodologies, and two innovative less lethal weapons.